Reverse Time Wellness INC
- PRP Therapy
- Shockwave Therapy
- IV Therapy
- Arthritis Treatment
- Erectile Dysfunction (ED) Treatment
Stamford, CT
stem cell therapy consult rooms in Stamford CT sit along I-95 Stamford exits, Washington Blvd / downtown medical corridor, and Glenbrook / Shippan drive-time suites, more than spa calendars. Local stem cell therapy clinics pack cash-pay menus between orthopedics referrals and drive-time regenerative pitches aimed at metro and suburb patients alike. A neighboring suburb commute changes who books follow-up, not product sourcing math. This hub is Stamford CT listings, not Greenwich or New Haven paste.
Source tissue claims, processing methods, and follow-up imaging all change what you buy. A lobby claim of "stem cell cure" is marketing until you see the written protocol and consent language.
This hub lists Directory clinics for Stamford CT and stem cell therapy. Inclusion is not an endorsement. Listing order is not paid ranking. Regenerated.com is free for patients. Featured slots stay labeled; Verified means credential checks, not spend.
Ask what tissue source they use, how the product is processed, what FDA framing they give, what contraindications they screen, and what happens if outcomes do not match the brochure. Local freeways shape booking windows, not the underlying biology. Prefer plain risk talk and written consent. Use the national stem cell therapy Directory and Guide, then return here.
Before you trust badges and counts on this page, read How to read a Regenerated city hub and Featured vs Verified vs organic. Then return here for local listings.
Regulatory context
In Connecticut, cellular therapies are governed by federal rules at 21 CFR Part 1271. Minimally manipulated HCT/Ps for homologous use fall under Section 361 and do not require premarket approval. Products that are more than minimally manipulated, used non-homologously, or combined with another article are Section 351 biologics that require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, exosome, and culture-expanded mesenchymal cell therapies offered for orthopedic, neurologic, and longevity indications fall under Section 351 and lack FDA approval.
The FDA has inspected and corresponded with Connecticut providers offering cellular and exosome therapies, and warning letters have been issued for unapproved biologic claims. The Connecticut Department of Public Health and the Medical Examining Board have authority to discipline physicians for unprofessional conduct, including misleading regenerative medicine advertising. The Connecticut Attorney General has used the Connecticut Unfair Trade Practices Act to investigate deceptive health claims. No widely publicized state injunction specific to stem cell clinics has been issued, but enforcement risk tracks federal action.
Available here
Nationwide
Stem Cell Therapy clinics across the US